Editorial: Model organisms in experimental pharmacology and drug discovery
| dc.contributor.author | Nainu, F | |
| dc.contributor.author | Jota-Baptista, C | |
| dc.contributor.author | Faustino-Rocha, Ana I | |
| dc.contributor.author | Oliveira, PA | |
| dc.date.accessioned | 2024-10-10T16:16:48Z | |
| dc.date.available | 2024-10-10T16:16:48Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | Model organisms are non-human species that have long been recognized as one of the crucial pillars in research, particularly in the field of experimental pharmacology and drug discovery (Hau, 2008). These organisms are widely employed in preclinical settings, providing a convenient way to model human diseases, explore the prospective pharmacological and toxicological effects of drug candidates, and elucidate the uncharted mechanisms of their action (Jota Baptista et al., 2022). Hence, studies using model organisms are essential for achieving scientifically sound progress within the field. | por |
| dc.identifier.authoremail | nd | |
| dc.identifier.authoremail | nd | |
| dc.identifier.authoremail | anafaustino@uevora.pt | |
| dc.identifier.authoremail | nd | |
| dc.identifier.citation | Nainu F, Jota-Baptista C, Faustino-Rocha A, PA Oliveira. 2023. Editorial: Model organisms in experimental pharmacology and drug discovery. Frontiers in Pharmacology 14: 1143934. Doi: 10.3389/fphar.2023.1143934. | por |
| dc.identifier.uri | https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2023.1143934/full | |
| dc.identifier.uri | http://hdl.handle.net/10174/37419 | |
| dc.language.iso | eng | por |
| dc.peerreviewed | yes | por |
| dc.publisher | Frontiers in Pharmacology | por |
| dc.rights | openAccess | por |
| dc.title | Editorial: Model organisms in experimental pharmacology and drug discovery | por |
| dc.type | article | por |